Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.82
Delayed Data
As of Dec 02
 +0.17 / +10.30%
Today’s Change
0.65
Today|||52-Week Range
1.98
+116.38%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close1.65
Today’s open1.63
Day’s range1.63 - 1.82
Volume67,691
Average volume (3 months)96,528
Market cap$123.0M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.62%
P/E ratioNM
Price/Sales1.02
Price/Book4.25

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...0.000.00%
PDEXPro-Dex Inc0.000.00%
ALGNAlign Technology Inc-0.08-0.09%
XRAYDentsply Sirona Inc-0.55-0.96%
Data as of 4:01pm ET, 12/02/2016

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$48.1M
Annual profit (last year)-$20.3M
Net profit margin-42.15%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts


Search for Jobs